Qsemble Capital Management, LP
Position in VKTX — Viking Therapeutics, Inc.
CIK 1766159
New York, NY
Position in VKTX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,871,348
-$740,898 QoQ
Shares Held
47,971
-40.2% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#124
of 432 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qsemble Capital Management, LP holds $7,848,553 across 6 Biotechnology names. VKTX ranks #3 (23.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
31,633 | $2,356,025 | |
| 2 | INSM |
INSMED Inc
|
21,148 | $2,254,799 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
This page
|
47,971 | $1,871,348 | |
| 4 | RPRX |
Royalty Pharma plc
|
10,675 | $598,547 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
5,639 | $459,634 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
3,887 | $308,200 |
All Filings in VKTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,871,348 | 47,971 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,612,246 | 80,278 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,246,110 | 35,421 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,869,874 | 71,152 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $697,082 | 26,305 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $336,578 | 13,937 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||